Genetic Engineering and Biotechnology News

spatial

How Spatial Biology Is Unlocking a New Dimension in Cancer Research

Credit: Hwang Lab, Harvard Medical School, Mass General Cancer Center

Panelists:

Image of Arutha Kulasinghe, PhD

Arutha Kulasinghe, PhD

Associate Professor, University of Queensland
Senior Research Fellow, Clinical-oMx Lab, Frazer Institute
Founding Scientific Director, Queensland Spatial Biology Centre, Wesley Research Institute

Panelist

Image of Arutha Kulasinghe, PhD

Arutha Kulasinghe, PhD

Arutha Kulasinghe, PhD, is an Associate Professor at the University of Queensland and a Senior Research Fellow at the Clinical-oMx Lab within the Frazer Institute. He also serves as the Founding Scientific Director of the Queensland Spatial Biology Centre (QSBC) at the Wesley Research Institute.

Image of Peter Sorger, PhD

Peter Sorger, PhD

Otto Krayer Professor
Department of Systems Biology
Head of the Harvard Program in Therapeutic Sciences – HiTS
Harvard Medical School

Panelist

Image of Peter Sorger, PhD

Peter Sorger, PhD

Peter Sorger, PhD
Otto Krayer Professor
Department of Systems Biology
Head of the Harvard Program in Therapeutic Sciences – HiTS
Harvard Medical School

Broadcast Date: 
  • Time: 

Spatial biology is propelling cancer research into a new era, offering unprecedented resolution into the tumor microenvironment, immune infiltration, and cellular heterogeneity at the single-cell level.

While spatial technologies have advanced many areas of biology, cancer research has arguably benefited the most. In this episode of GEN Live, we explore how spatial technology is advancing the field of cancer research. What new questions can we now ask? What insights are emerging? And how might these technologies impact clinical care and patient outcomes?

Joining us are leading researchers who are pushing the boundaries of cancer science using cutting-edge spatial tools. They’ll share how they’re mapping tumor ecosystems in ways that were unthinkable just a few years ago—and what that could mean for the future of cancer diagnostics, prognostics, and precision therapeutics.

There was also a live Q&A session, where attendees had the chance to engage directly with our expert panel.

Produced with support from:

illumina logo